J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need - The New York Times
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.
He said the company was continuing to deliver batches of the vaccine to facilities that bottled and packaged doses. He also said Johnson & Johnson had millions of finished doses in inventory.
Jo… [+1802 chars]
Read More
Other Stories in Business
- V-Guard Q1 Results Review - Summer Products Led Healthy Quarter; Improved Outlook Priced In: Systematix
- Nestle India Q1 Review - Tepid Results; Commodity Cost Headwinds Emerging: Nirmal Bang
- Revolutionizing Imaging: The Capabilities of the IMX415 Sensor
- Generative AI in Material Science Market is expected to grow to USD 8,486 million by 2032 from USD 667 million in 2022, at a CAGR of 29.8%
- Brokerage Views On Budget Day: Citi On Exide, GAIL; Nuvama On Oberoi Realty And More
- PhonePe, Google Pay Cede Online Payment Share To New Entrants
- JK Cement Q1 Results Review - Weak Volume Growth Impairs Ebitda Growth; Maintain Hold: Systematix
- RBI Sold $406 Million India Bonds As Index Inclusion Spurs Flows
- Woman’s corpse with gunshots found near M’sia-Thailand border
